Serotonin not only promoted cardiac fibrosis and pulmonary fibrosis by activating the TGF-β signaling pathway [119, 120] but also enhanced β-catenin signaling by inhibiting GSK3β [121]. The gene discussed is GSK3B; the disease is pulmonary fibrosis.